[Federal Register: January 22, 2004 (Volume 69, Number 14)]
[Notices]
[Page 3147-3148]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22ja04-56]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Neurological Indices of Long Term Solvent Exposure in
Workers, Request for Applications OH-04-001
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Neurological Indices of Long Term Solvent
Exposure in Workers, Request for Applications OH-04-001.
Times and Dates: 6 p.m.-6:30 p.m., February 11, 2004 (open); 6:30
p.m.-8 p.m., February 11, 2004 (closed); 9 a.m.-5 p.m., February 12,
2004 (closed); 9 a.m.-5 p.m., February 13, 2004 (closed).
Place: Embassy Suites Hotels, 1900 Diagonal Road, Alexandria, VA
22314, telephone 703-684-5900.
[[Page 3148]]
Status: Portions of the meeting will be closed to the public in
accordance with provisions set forth in section 552b(c) (4) and (6),
title 5 U.S.C., and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to
Request for Applications: OH-04-001.
Contact Person for More Information: Pervis C. Major, Ph.D.,
Scientific Review Administrator, Office of Extramural Programs,
National Institute for Occupational Safety and Health, CDC, 1095
Willowdale Road, Morgantown, WV 26505, telephone 304-285-5979.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: January 14, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 04-1303 Filed 1-21-04; 8:45 am]
BILLING CODE 4163-19-P